SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Kymab And Wellcome Trust Sign £20 Million Financing To Build A UK Biopharmaceutical Company Based On Human Monoclonal Antibody Technology From The Sanger Institute